Related references
Note: Only part of the references are listed.Respiratory Virus-Induced TLR7 Activation Controls IL-17-Associated Increased Mucus via IL-23 Regulation
Nicholas W. Lukacs et al.
JOURNAL OF IMMUNOLOGY (2010)
Tc17 Cells Are Capable of Mediating Immunity to Vaccinia Virus by Acquisition of a Cytotoxic Phenotype
Norman Yeh et al.
JOURNAL OF IMMUNOLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Proinflammatory T helper type 17 cells are effective B-cell helpers
Meike Mitsdoerffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
Toon Stegmann et al.
VACCINE (2010)
In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
John J. LiPuma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice
J. Kovacs-Nolan et al.
JOURNAL OF GENERAL VIROLOGY (2009)
IL-10 Deficiency Unleashes an Influenza-Specific Th17 Response and Enhances Survival against High-Dose Challenge
K. Kai McKinstry et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels
Zeina Jaffar et al.
JOURNAL OF IMMUNOLOGY (2009)
A Functional IL-13 Receptor Is Expressed on Polarized Murine CD4+ Th17 Cells and IL-13 Signaling Attenuates Th17 Cytokine Production
Dawn C. Newcomb et al.
JOURNAL OF IMMUNOLOGY (2009)
Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
Hiromasa Hamada et al.
JOURNAL OF IMMUNOLOGY (2009)
A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction
Martin L. Moore et al.
JOURNAL OF VIROLOGY (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates
Anna U. Bielinska et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation
Matthew A. Schaller et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Human and bovine respiratory syncytial virus vaccine research and development
Gilles Meyer et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2008)
CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8+ T cell efficacy
Dennis M. Lindell et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Overcoming T-cell-mediated immunopathology to achieve safe respiratory syncytial virus vaccination
Elaine M. Castilow et al.
FUTURE VIROLOGY (2008)
Interferon-alpha controls IL-17 expression in vitro and in vivo
Alexander R. Moschen et al.
IMMUNOBIOLOGY (2008)
Role of Th1 and Th17 cells in organ-specific autoimmunity
Valerie Dardalhon et al.
JOURNAL OF AUTOIMMUNITY (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Paul E. Makidon et al.
PLOS ONE (2008)
B Cell Antigen Presentation Promotes Th2 Responses and Immunopathology during Chronic Allergic Lung Disease
Dennis M. Lindell et al.
PLOS ONE (2008)
A novel, killed-virus nasal vaccinia virus vaccine
Anna U. Bielinska et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-γ production
Joost J. Smit et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Interleukin-17 in pulmonary host defense
Shean J. Aujla et al.
EXPERIMENTAL LUNG RESEARCH (2007)
IL-23 enhances host Defense against vaccinia virus infection via a mechanism partly involving IL-17
Shunsuke Kohyama et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection
Shahina Wiehler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge
Anna U. Bielinska et al.
INFECTION AND IMMUNITY (2007)
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
Elaine M. Castilow et al.
IMMUNOLOGIC RESEARCH (2007)
Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus
Nicholas W. Lukacs et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus
SM Perkins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Attenuation of allergen-induced responses in CCR6-/- mice is dependent upon altered pulmonary T lymphocyte activation
SK Lundy et al.
JOURNAL OF IMMUNOLOGY (2005)
Temporal production of CCL28 corresponds to eosinophil accumulation and airway Hyperreactivity in allergic airway inflammation
AE John et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses
AE John et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Respiratory syncytial virus-induced chemokine production: Linking viral replication to chemokine production in vitro and in vivo
AL Miller et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The future of respiratory syncytial virus vaccine development
FP Polack et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion
A Myc et al.
VACCINE (2003)
Inactivation of Ebola virus with a surfactant nanoemulsion
AA Chepurnov et al.
ACTA TROPICA (2003)
Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection
RC Welliver
JOURNAL OF PEDIATRICS (2003)
The fungicidal activity of novel nanoemulsion (X8W(60)PC) against clinically important yeast and filamentous fungi
A Myc et al.
MYCOPATHOLOGIA (2002)
The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity
D Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi
T Hamouda et al.
MICROBIOLOGICAL RESEARCH (2001)
Share Paper
